GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients.

导出 LinkOut

翻译打印收藏纠错

第一作者： Yaqiong,Li

第一单位： Department of Cell Biology, School of Basic Medical Science, Capital Medical University, Beijing, 100069, China.

作者： Yaqiong,Li ^[1] ; Yi,Lin ^[2] ; Xueya,Han ^[1] ; Weihong,Li ^[1] ; Wenmao,Yan ^[2] ; Yuejiao,Ma ^[1] ; Xin,Lu ^[1] ; Xiaowu,Huang ^[3] ; Rixing,Bai ^[2] ; Haiyan,Zhang ^[1]

作者单位： Department of Cell Biology, School of Basic Medical Science, Capital Medical University, Beijing, 100069, China. ^[1] Department of General Surgery, Beijing Tian Tan Hospital, Capital Medical University, Beijing, 100070, China. ^[2] Fu Xing Hospital, Capital Medical University, Beijing, 100038, China. ^[3]

关键词 human metabolism molecular biology

DOI 10.1016/j.isci.2021.102149

PMID 33665568

发布时间 2021-03-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

iScience

2021年24卷3期

102149页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients.

iScience

相似文献

iScience

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

GSK3 inhibitor ameliorates steatosis through the modulation of mitochondrial dysfunction in hepatocytes of obese patients.

iScience

相似文献

iScience

相关期刊

检索历史清除